Stock Movers

iHeartPodcasts
undefined
6 snips
Feb 9, 2026 • 5min

Closing Bell: Applovin, Oracle Rise; Hims & Hers Health, Workday Fall

Stocks swing after a major publisher retracts explosive claims linking a mobile ad firm to illicit activity. Software giant shares rally on renewed optimism tied to big tech capital spending and AI. A health company faces legal trouble over alleged copycat obesity drugs while workforce software moves falter amid leadership changes.
undefined
Feb 9, 2026 • 5min

Oracle Surges; Kyndryl, Hims & Hers Health Plummet

Carmen Reinecke, Bloomberg equities reporter and deputy U.S. equities team lead, breaks down today’s market movers. She highlights Oracle’s sharp rebound tied to big-tech capex and AI ties. She walks through Kyndryl’s dramatic plunge after leadership exits and accounting reviews. She covers Hims & Hers’ stock collapse amid a lawsuit over compounded weight-loss drugs.
undefined
Feb 9, 2026 • 2min

Hims & Hers Falls, Kroger Rises, Monday.com Sinks on Weak Forecast

Norma Linda, Bloomberg Television markets correspondent who analyzes notable stock moves. She covers Novo Nordisk suing Hims & Hers over alleged copycat obesity drugs. She explains Kroger’s stock pop after naming a new CEO and resetting guidance. She also discusses Monday.com’s weak revenue forecast and the risks to seat-based software models.
undefined
Feb 9, 2026 • 3min

Alphabet Down, Hims & Hers Health Tumbles, Tegna Rises After Trump Backs Nexstar Deal

Big tech taps the bond market to fund AI infrastructure with a large dollar offering. A telehealth company plunges after backing away from a weight-loss pill amid legal trouble. Broadcaster shares jump following a high-profile political endorsement of a proposed media merger.
undefined
Feb 9, 2026 • 4min

Novo Says It’s Suing Hims; Lilly Strikes Deal for Biotech Orna; Alphabet Looks to Raise About $15 Billion

A legal clash over semaglutide knockoffs and a telehealth company pulling its copycat weight-loss pill. A major pharma expands into RNA-based autoimmune therapies with a multibillion-dollar deal. A tech giant plans a roughly $15 billion bond sale amid a surge in AI infrastructure spending by hyperscalers.
undefined
Feb 9, 2026 • 4min

Hims & Hers Sinks; Kroger's Next CEO; STMicro Rises

Coverage of a telehealth company pulling a Wegovy-copy pill amid regulatory scrutiny. Discussion of Kroger naming a new CEO as the supermarket reshapes strategy after a failed megadeal. A chipmaker's stock jumps on an expanded collaboration with Amazon AWS tied to AI data center opportunities.
undefined
Feb 9, 2026 • 4min

Novo Rebounds, Greggs Drops, UniCredit Pays Out

Louise Moon, Bloomberg breaking news editor who covers market-moving company news. She walks through Novo Nordisk’s rebound after a copycat pill was pulled. She covers Hims & Hers’ stock fallout and Jefferies’ downgrade of Greggs tied to weight-loss drugs. She also explains UniCredit’s plan to return about €50 billion and lift profitability.
undefined
Feb 9, 2026 • 5min

Novo Rebounds, Natwest Buys, InPost Deal

Chloe Malay, Bloomberg reporter who covers European markets and corporate news, breaks down market-moving deals. She explains Novo Nordisk’s stock rebound after regulators sidelined a copycat drug. She covers NatWest’s big purchase to boost wealth management. She walks through the €7.8bn InPost takeover led by Advent and FedEx.
undefined
Feb 8, 2026 • 6min

Week Ahead: Cisco, McDonalds, T-Mobile

Bailey Lipschultz, Senior Equities Reporter at Bloomberg News, previews upcoming corporate reports and market movers. She highlights Cisco’s AI-driven hardware rally and capacity questions. She outlines McDonald’s mix of value meals, traffic versus margin tradeoffs. She also discusses T-Mobile’s sideways stock, pricing competition and potential capital returns.
undefined
Feb 6, 2026 • 7min

Amazon, Coinbase Drop; Tapestry Rises

Emily Grafeo, Bloomberg cross-asset reporter who covers tech and crypto movers. She breaks down Amazon’s massive AI-focused spending plan and why it rattled investors. She discusses Coinbase’s struggles as crypto weakness weighs on trading. She also highlights Tapestry’s upbeat guidance and its momentum with younger shoppers.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app